Skip to main content
Year archive

Genscript Biotech Corporation — 2022 filings

All 89 regulatory filings released by Genscript Biotech Corporation (1548) in 2022, sourced directly from the official regulator.

89 Filings
2022 Period
2022 filings (89)
Filing Released Lang
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Regulatory Filings
2022-12-18 English
REDESIGNATION OF DIRECTOR AND APPOINTMENT OF ROTATING CHIEF EXECUTIVE OFFICER
Regulatory Filings
2022-12-18 English
Next Day Disclosure Return
Regulatory Filings
2022-12-14 English
OVERSEAS REGULATORY ANNOUNCEMENT: LEGEND BIOTECH UPDATES PIPELINE OF PRODUCT CANDIDATES
Regulatory Filings
2022-12-08 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2022
Regulatory Filings
2022-12-05 English
Next Day Disclosure Return
Regulatory Filings
2022-12-04 English
VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE
Regulatory Filings
2022-11-21 English
VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE
Regulatory Filings
2022-11-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2022
Regulatory Filings
2022-11-03 English
INSIDE INFORMATION: PROPOSED RESTATEMENT OF LEGEND BIOTECH'S FINANCIAL STATEMENTS AND OVERSEAS REGULATORY ANNOUNCEMENT
Regulatory Filings
2022-10-21 English
INSIDE INFORMATION: PROPOSED RESTATEMENT OF THE COMPANY'S FINANCIAL STATEMENTS ARISING FROM PROPOSED RESTATEMENT OF LEGEND BIOTECH'S FINANCIAL STATEMENTS AND OVERSEAS REGULATORY ANNOUNCEMENT
Regulatory Filings
2022-10-21 English
VOLUNTARY ANNOUNCEMENT: PRELIMINARY SALES FOR CARVYKTI TM FOR THE QUARTER ENDED 30 SEPTEMBER 2022
Regulatory Filings
2022-10-19 English
OVERSEAS REGULATORY ANNOUNCEMENT: LEGEND BIOTECH ANNOUNCES RESULTS OF ANNUAL GENERAL MEETING
Regulatory Filings
2022-10-18 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2022
Regulatory Filings
2022-10-07 English
OVERSEAS REGULATORY ANNOUNCEMENT: LEGEND BIOTECH ANNOUNCES ENTERING INTO THE AMENDED AND RESTATED EMPLOYMENT AGREEMENT WITH CHIEF FINANCIAL OFFICER
Regulatory Filings
2022-10-04 English
CLARIFICATION ON CHINESE VERSION OF VOLUNTARY ANNOUNCEMENT RESEARCH AND DEVELOPMENT UPDATE
Regulatory Filings
2022-09-28 English
VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE
Regulatory Filings
2022-09-27 English
NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS AND REQUEST FORM - NOTICE OF PUBLICATION OF 2022 INTERIM REPORT
Regulatory Filings
2022-09-23 English
NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND CHANGE REQUEST FORM - NOTICE OF PUBLICATION OF 2022 INTERIM REPORT
Regulatory Filings
2022-09-23 English
INTERIM REPORT 2022
Regulatory Filings
2022-09-23 English
VOLUNTARY ANNOUNCEMENT: RESEARCH AND DEVELOPMENT UPDATE
Regulatory Filings
2022-09-15 English
GRANT OF RESTRICTED SHARES AND SUPPLEMENTAL ANNOUNCEMENT ON THE AMENDMENT TO THE 2021 RESTRICTED SHARE AWARD SCHEME
Regulatory Filings
2022-09-09 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2022
Regulatory Filings
2022-09-06 English
GRANT OF RESTRICTED SHARES AND SUPPLEMENTAL ANNOUNCEMENT ON THE AMENDMENT TO THE 2021 RESTRICTED SHARE AWARD SCHEME
Regulatory Filings
2022-09-02 English
ANNOUNCEMENT OF UNAUDITED CONSOLIDATED INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2022
Regulatory Filings
2022-08-31 English
DATE OF BOARD MEETING
Regulatory Filings
2022-08-19 English
CLARIFICATION ON PROFIT WARNING
Regulatory Filings
2022-08-08 English
PROFIT WARNING
Regulatory Filings
2022-08-07 English
OVERSEAS REGULATORY ANNOUNCEMENT: PRELIMINARY RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2022 OF A LISTED SUBSIDIARY - LEGEND BIOTECH CORPORATION
Regulatory Filings
2022-08-05 English
OVERSEAS REGULATORY ANNOUNCEMENT: LEGEND BIOTECH ANNOUNCES NEW APPOINTMENT TO THE BOARD OF DIRECTORS
Regulatory Filings
2022-08-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2022
Regulatory Filings
2022-08-04 English
COMPLETION OF THE FOLLOW-ON PUBLIC OFFERING OF LEGEND BIOTECH CORPORATION
Regulatory Filings
2022-07-31 English
(1) UPDATE ON THE FOLLOW-ON PUBLIC OFFERING BY LEGEND BIOTECH CORPORATION (2) OVERSEAS REGULATORY ANNOUNCEMENT
Regulatory Filings
2022-07-28 English
UPDATE ON THE FOLLOW-ON PUBLIC OFFERING BY LEGEND BIOTECH CORPORATION
Regulatory Filings
2022-07-27 English
DISCLOSEABLE TRANSACTION: FOLLOW-ON PUBLIC OFFERING BY LEGEND BIOTECH CORPORATION AND OVERSEAS REGULATORY ANNOUNCEMENT
Regulatory Filings
2022-07-26 English
VOLUNTARY ANNOUNCEMENT: PRELIMINARY SALES FOR CARVYKTI TM FOR THE QUARTER ENDED 30 JUNE 2022
Regulatory Filings
2022-07-21 English
VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE
Regulatory Filings
2022-07-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2022
Regulatory Filings
2022-07-07 English
COMPLETION OF THE DEEMED DISPOSAL OF EQUITY INTEREST IN PROBIO CAYMAN
Regulatory Filings
2022-07-06 English
INSIDE INFORMATION: DEEMED DISPOSAL OF EQUITY INTEREST IN PROBIO CAYMAN
Regulatory Filings
2022-07-04 English
VOLUNTARY ANNOUNCEMENT: ACQUISITION OF PROPERTIES
Regulatory Filings
2022-06-29 English
Next Day Disclosure Return
Regulatory Filings
2022-06-27 English
Next Day Disclosure Return
Regulatory Filings
2022-06-24 English
Next Day Disclosure Return
Regulatory Filings
2022-06-22 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2022
Regulatory Filings
2022-06-07 English
VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE
Regulatory Filings
2022-06-05 English
VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE
Regulatory Filings
2022-06-05 English
OVERSEAS REGULATORY ANNOUNCEMENT - UNAUDITED FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED 31 MARCH 2022 BY A LISTED SUBSIDIARY - LEGEND BIOTECH CORPORATION
Regulatory Filings
2022-06-01 English
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 27 MAY 2022
Regulatory Filings
2022-05-27 English
GRANT OF RESTRICTED SHARES
Regulatory Filings
2022-05-27 English
AMENDMENT TO THE 2021 RESTRICTED SHARE AWARD SCHEME
Regulatory Filings
2022-05-26 English
VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE
Regulatory Filings
2022-05-26 English
VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE
Regulatory Filings
2022-05-18 English
SECOND FORM OF PROXY FOR 2022 ANNUAL GENERAL MEETING
Regulatory Filings
2022-05-11 English
SUPPLEMENTAL NOTICE OF ANNUAL GENERAL MEETING
Regulatory Filings
2022-05-11 English
SUPPLEMENTAL CIRCULAR: RE-ELECTION OF A NON-EXECUTIVE DIRECTOR AND SUPPLEMENTAL NOTICE OF ANNUAL GENERAL MEETING
Regulatory Filings
2022-05-11 English
OVERSEAS REGULATORY ANNOUNCEMENT: LEGEND BIOTECH ANNOUNCES CHANGE IN REGISTRANT'S CERTIFYING ACCOUNTANT
Regulatory Filings
2022-05-09 English
OVERSEAS REGULATORY ANNOUNCEMENT: LEGEND BIOTECH ANNOUNCES APPOINTMENT OF CHIEF FINANCIAL OFFICER
Regulatory Filings
2022-05-09 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2022
Regulatory Filings
2022-05-06 English
Risk Management Committee - Terms of Reference
Regulatory Filings
2022-05-03 English
Strategy Committee - Terms of Reference
Regulatory Filings
2022-05-03 English
APPOINTMENT OF NON-EXECUTIVE DIRECTOR, ESTABLISHMENT OF THE RISK MANAGEMENT COMMITTEE AND ESTABLISHMENT OF THE STRATEGY COMMITTEE
Regulatory Filings
2022-05-03 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Regulatory Filings
2022-05-03 English
UPDATE ON THE INVESTIGATION
Regulatory Filings
2022-05-03 English
FORM OF PROXY FOR 2022 ANNUAL GENERAL MEETING
Regulatory Filings
2022-04-25 English
PROPOSALS FOR GRANTING OF GENERAL MANDATES TO ISSUE NEW SHARES AND TO REPURCHASE SHARES, RE-ELECTION OF RETIRING DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING
Regulatory Filings
2022-04-25 English
NOTICE OF ANNUAL GENERAL MEETING
Regulatory Filings
2022-04-25 English
ANNUAL REPORT 2021
Regulatory Filings
2022-04-25 English
INSIDE INFORMATION - ACHIEVING MAJOR MILESTONE IN THE COLLABORATION WITH JANSSEN BIOTECH, INC.
Regulatory Filings
2022-04-21 English
OVERSEAS REGULATORY ANNOUNCEMENT: LEGEND BIOTECH ANNOUNCES IDENTIFICATION UNDER THE HOLDING FOREIGN COMPANIES ACCOUNTABLE ACT
Regulatory Filings
2022-04-14 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2022
Regulatory Filings
2022-04-07 English
OVERSEAS REGULATORY ANNOUNCEMENT - LEGEND BIOTECH ANNOUNCES APPOINTMENT OF GLOBAL HEAD OF RESEARCH AND EARLY DEVELOPMENT
Regulatory Filings
2022-04-03 English
OVERSEAS REGULATORY ANNOUNCEMENT ANNUAL REPORT FOR THE YEAR ENDED 31 DECEMBER 2021 BY A LISTED SUBSIDIARY - LEGEND BIOTECH CORPORATION
Regulatory Filings
2022-03-31 English
VOLUNTARY ANNOUNCEMENT: RESEARCH AND DEVELOPMENT UPDATE
Regulatory Filings
2022-03-25 English
Grant of Restricted Shares
Regulatory Filings
2022-03-22 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2021
Regulatory Filings
2022-03-20 English
OVERSEAS REGULATORY ANNOUNCEMENT: FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FULL YEAR ENDED 31 DECEMBER 2021 OF A LISTED SUBSIDIARY - LEGEND BIOTECH CORPORATION
Regulatory Filings
2022-03-20 English
DATE OF BOARD MEETING
Regulatory Filings
2022-03-09 English
OVERSEAS REGULATORY ANNOUNCEMENT: LEGEND BIOTECH ANNOUNCES ENTERING INTO THE INTERIM PRODUCT SUPPLY AGREEMENT WITH JANSSEN
Regulatory Filings
2022-03-08 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2022
Regulatory Filings
2022-03-04 English
VOLUNTARY ANNOUNCEMENT: RESEARCH AND DEVELOPMENT UPDATE
Regulatory Filings
2022-03-01 English
PROFIT WARNING
Regulatory Filings
2022-02-18 English
OVERSEAS REGULATORY ANNOUNCEMENT PRELIMINARY RESULTS FOR THE YEAR ENDED 31 DECEMBER 2021 OF A LISTED SUBSIDIARY - LEGEND BIOTECH CORPORATION
Regulatory Filings
2022-02-18 English
VOLUNTARY ANNOUNCEMENT RESEARCH AND DEVELOPMENT UPDATE
Regulatory Filings
2022-02-15 English
INSIDE INFORMATION - ACHIEVING MAJOR MILESTONES IN THE COLLABORATION WITH JANSSEN BIOTECH, INC.
Regulatory Filings
2022-02-11 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2022
Regulatory Filings
2022-02-08 English
OVERSEAS REGULATORY ANNOUNCEMENT: LEGEND BIOTECH ANNOUNCES TERMINATION OF COLLABORATIVE RESEARCH AND LICENSE AGREEMENT WITH NOILE
Regulatory Filings
2022-02-03 English
Grant of Restricted Shares
Regulatory Filings
2022-01-10 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2021
Regulatory Filings
2022-01-06 English